Evidence map›Paper›PMID 29998808›Full record

ReviewCurrent pediatric reviews2018

Neonatal and Long-Term Consequences of Fetal Growth Restriction.

Marina Colella, Alice Frérot, Aline Rideau Batista Novais, Olivier Baud

Registry-linked trialAbstract readReview
In one paragraph

Review in Current pediatric reviews, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05029778 (Efficacy L-arginine + L-citrulline as a Dietary Supplement vs Placebo for Weight Gain in Fetus With a Decrease in Their Growth Curve in the Third Trimester of Pregnancy), which is not on this map. Cited by 74 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 2 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05029778 phase4unknown statusnot on this mapstarted 2021, after this paper: background citation

Efficacy L-arginine + L-citrulline as a Dietary Supplement vs Placebo for Weight Gain in Fetus With a Decrease in Their Growth Curve in the Third Trimester of Pregnancy

TypeinterventionalSponsorHospital Civil de GuadalajaraRan2021 to 2024Enrolled41ConditionsFetal Growth RetardationArmsL-arginine 3g + L-Citruline 2 g, Placebo
3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 2 syntheses or guidelines pooled it, 155 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Endothelial Progenitor Cells in Life, Pregnancy and Disease.Expert reviews in molecular medicine · 2025
    Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Marina ColellaUniversity Paris Diderot, Sorbone Paris-Cite, Inserm U1141, Neonatal intensive care unit, Assistance Publique- Hopitaux de Paris, Robert Debre Children's hospital, Paris, France.
Alice FrérotUniversity Paris Diderot, Sorbone Paris-Cite, Inserm U1141, Neonatal intensive care unit, Assistance Publique- Hopitaux de Paris, Robert Debre Children's hospital, Paris, France.
Aline Rideau Batista NovaisUniversity Paris Diderot, Sorbone Paris-Cite, Inserm U1141, Neonatal intensive care unit, Assistance Publique- Hopitaux de Paris, Robert Debre Children's hospital, Paris, France.
Olivier BaudUniversity Paris Diderot, Sorbone Paris-Cite, Inserm U1141, Neonatal intensive care unit, Assistance Publique- Hopitaux de Paris, Robert Debre Children's hospital, Paris, France.
Délégation Paris 7 · FRInserm · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFetal Growth Restriction (FGR) is one of the most common noxious antenatal conditions in humans, inducing a substantial proportion of preterm delivery and leading to a significant increase in perinatal mortality, neurological handicaps and chronic diseases in adulthood. This review summarizes the current knowledge about the postnatal consequences of FGR, with a particular emphasis on the long-term consequences on respiratory, cardiovascular and neurological structures and functions. RESULT AND

conclusionFGR represents a global health challenge, and efforts are urgently needed to improve our understanding of the critical factors leading to FGR and subsequent insults to the developing organs.

Indexed as

AnimalsFemaleFetal Growth RetardationHumansInfant, NewbornInfant, Newborn, DiseasesPerinatal MortalityPregnancydiseasesFGRlong-term handicapmaternal malnutritionneonatal brain injuryperinatal mortality.

Identifiers

PMID29998808
PMCPMC6416241
OpenAlexW2865984904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.